XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
3 Months Ended 6 Months Ended 141 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS [Abstract]          
Research and development expenses, net $ 461,303 $ 508,462 $ 965,548 $ 953,528 $ 11,441,952
General and administrative expenses 370,491 245,613 554,070 448,548 3,568,712
Other income             (912)
Operating loss 831,794 754,075 1,519,618 1,402,076 15,009,752
Financing expenses (income), net (255,197) (16,617) 400,574 [1] (29,665) 2,200,266
Loss for the period 576,597 737,458 1,920,192 1,372,411 17,210,018
Other comprehensive (income) loss:          
Foreign currency translation adjustment 12,447 (32,704) 18,800 (21,143) 27,725
Comprehensive loss for the period $ 589,044 $ 704,754 $ 1,938,992 $ 1,351,268 $ 17,237,743
Loss per share for the period attributable to common stockholders (Basic and Diluted) (Note 4) $ 0.13 $ 0.14 $ 0.38 $ 0.26   
Weighted average number of shares outstanding (Basic and Diluted) (Note 4) 5,297,693 5,295,543 5,363,302 5,295,543   
[1] Including issuance costs in an amount of US$ 390,928 allocated to the warrants with "down-round" protection. (See Note 3).